Worldwide Survey of Clinician Practice on use of Adjunctive Therapies Following Botulinum Toxin Injection for Spasticity
- PMID: 35801863
- PMCID: PMC9511365
- DOI: 10.2340/jrm.v54.334
Worldwide Survey of Clinician Practice on use of Adjunctive Therapies Following Botulinum Toxin Injection for Spasticity
Abstract
Objective: Non-pharmacological adjunctive therapies can be used alongside botulinum toxin injection to enhance its efficacy. The objective of this global study was to determine the current practice and perception among clinicians of the use of adjunctive therapies after botulinum toxin injections for the treatment of limb spasticity.
Methods: A questionnaire with 22 questions on clinical practice demographics, self-reported use and clinician opinion on barriers to the use of complementary therapies, and priorities for future research was translated into 7 languages and distributed worldwide through national and international professional associations concerning (neuro)rehabilitation.
Results: A total of 527 clinicians from 52 countries responded to the survey. Most commonly used physical interventions were: active exercise programmes at home (81%), stretching programmes at home (81%), and splinting (70%), followed by active movement exercises (65%) and within 30 min of botulinum toxin injection and constraint induced movement therapy (63%). The main barriers reported by clinicians to provision of these interventions were clinicians' lack of time, limited financial resources, and lack of evidence. Future research should focus primarily on immediate active movement exercises and passive stretching.
Conclusion: Worldwide, clinicians often recommend adjunctive therapies after a botulinum toxin injection to reduce spasticity. The most commonly used physical interventions among clinicians were active exercises at home, stretching at home, and splinting. Lack of evidence, time and financial constraints were identified as barriers to providing these interventions.
Conflict of interest statement
FS has received honoraria from Allergan and Merz, MS has received honoraria from Allergan, SA has received honoraria and grant funding from Ipsen and honoraria from Allergan and Merz. JJ has received honoraria from Ipsen, Merz and Abbvie/Allergan for services as speaker, scientific advisor, researcher, and trainer. TD has received grants from Allergan and Merz. AI, MN, JM, NB, EC, MN, ES and PM have no conflicts of interest to declare.
Figures


Similar articles
-
Practice Patterns of Physicians Using Adjunct Therapies with Botulinum Toxin Injection for Spasticity: A Canadian Multicenter Cross-Sectional Survey.PM R. 2021 Apr;13(4):372-378. doi: 10.1002/pmrj.12442. Epub 2020 Aug 26. PM R. 2021. PMID: 32578339
-
Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review.Ann Phys Rehabil Med. 2019 Jul;62(4):283-290. doi: 10.1016/j.rehab.2018.06.010. Epub 2018 Jul 29. Ann Phys Rehabil Med. 2019. PMID: 30063979
-
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature.Ann Phys Rehabil Med. 2019 Jul;62(4):291-296. doi: 10.1016/j.rehab.2018.08.004. Epub 2018 Sep 13. Ann Phys Rehabil Med. 2019. PMID: 30219307 Review.
-
Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment.Syst Rev. 2012 Jun 26;1:29. doi: 10.1186/2046-4053-1-29. Syst Rev. 2012. PMID: 22734503 Free PMC article.
-
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.Clin Rehabil. 2015 Jan;29(1):50-8. doi: 10.1177/0269215514537915. Epub 2014 Jun 10. Clin Rehabil. 2015. PMID: 24917588 Clinical Trial.
Cited by
-
Best Practice Guidelines for the Management of Patients with Post-Stroke Spasticity: A Modified Scoping Review.Toxins (Basel). 2024 Feb 10;16(2):98. doi: 10.3390/toxins16020098. Toxins (Basel). 2024. PMID: 38393176 Free PMC article.
-
Ultrasound image guided injection of botulinum toxin for the management of spasticity: A Delphi study to develop recommendations for a scope of practice, competency, and governance framework.Arch Rehabil Res Clin Transl. 2023 Sep 29;5(4):100299. doi: 10.1016/j.arrct.2023.100299. eCollection 2023 Dec. Arch Rehabil Res Clin Transl. 2023. PMID: 38163024 Free PMC article.
-
Multimodal therapy and use of adjunctive therapies to BoNT-A in spasticity management: defining terminology to help enhance spasticity treatment.Front Neurol. 2024 Aug 30;15:1432330. doi: 10.3389/fneur.2024.1432330. eCollection 2024. Front Neurol. 2024. PMID: 39281409 Free PMC article.
-
Stretching exercises in managing spasticity: effectiveness, risks, and adjunct therapies.Eur J Transl Myol. 2024 Jun 13;34(2):12455. doi: 10.4081/ejtm.2024.12455. Eur J Transl Myol. 2024. PMID: 38872376 Free PMC article.
-
Safety of dry needling in stroke patients: a scoping review.Eur J Phys Rehabil Med. 2024 Apr;60(2):225-232. doi: 10.23736/S1973-9087.24.08224-8. Epub 2024 Mar 19. Eur J Phys Rehabil Med. 2024. PMID: 38502557 Free PMC article.
References
-
- Baude M, Nielsen J, Gracies JM. The neurophysiology of deforming spastic paresis: a revised taxonomy. Ann Phys Rehabil Med 2019; 62: 426–430. - PubMed
-
- Wissel J, Ward A, Erztgaard P, Bensmail D, Hecht M, Lejeune Tet al. . European Consensus table on the use of Botulinum Toxin Type A in adult spasticity. J Rehab Med 2009; 41: 13–25. - PubMed
-
- Mills P, Finlayson H, Sudol M, O’Connor R. Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity. Clin Rehabil 2016; 30: 537–548. - PubMed
-
- Picelli A, Santamato A, Chemello E, Cinone N, Cisari C, Gandolfi Met al. . Adjuvant treatments associated with botulinum toxin injection for managing spasticity : an overview of the literature. Ann Phys Rehabil Med 2019; 62: 291–296. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical